MedPath

Effect of Cyproheptadine on weight gain in childre

Not Applicable
Conditions
Growth retardation.
Cachexia
Registration Number
IRCT2014101318971N3
Lead Sponsor
Zanjan University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
68
Inclusion Criteria

Inclusion criteria include: all children aged 2 to 10 years with a weight below the 50th percentile; Children whose parents have given consent to participate in the study.
Exclusion criteria include: children with underlying organic condition (gastrointestinal, cardiovascular, respiratory, renal and nervous systems) causing growth failure; inappropriate use of medicines; discourage children from study; did not return for follow-up; occurs severe disease and side effects of medication.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Weight gain. Timepoint: Every month up to 2 months, 2 months after treatment. Method of measurement: Weighing the patient.
Secondary Outcome Measures
NameTimeMethod
Increase Height. Timepoint: Every month up to 2 months, 2 months after treatment. Method of measurement: height measurements.;Side Effects and complication. Timepoint: Every month up to 2 months, 2 months after treatment. Method of measurement: History and physical examination.
© Copyright 2025. All Rights Reserved by MedPath